Amalgamated Bank reduced its holdings in Acadia Healthcare Company, Inc. (NASDAQ:ACHC – Get Rating) by 3.3% in the first quarter, according to its most recent filing with the Securities & Exchange Commission. The institutional investor owned 62,054 shares of the company's stock after selling 2,141 shares during the period. Amalgamated Bank owned approximately 0.07% of Acadia Healthcare worth $4,066,000 as of its most recent filing with the Securities & Exchange Commission.

A number of other large investors have also recently made changes to their positions in ACHC. Invesco Ltd. boosted its stake in shares of Acadia Healthcare by 132.5% during the 4th quarter. Invesco Ltd. now owns 1,598,040 shares of the company's stock worth $97,000,000 after purchasing an additional 910,813 shares during the period. Alliancebernstein L.P. boosted its stake in shares of Acadia Healthcare by 26.3% during the 4th quarter. Alliancebernstein L.P. now owns 2,748,073 shares of the company's stock worth $166,808,000 after purchasing an additional 571,384 shares during the period. Millennium Management LLC boosted its stake in shares of Acadia Healthcare by 136.4% during the 4th quarter. Millennium Management LLC now owns 928,206 shares of the company's stock worth $56,342,000 after purchasing an additional 535,593 shares during the period. Alyeska Investment Group L.P. purchased a new position in shares of Acadia Healthcare during the 1st quarter worth about $28,751,000. Finally, Hawk Ridge Capital Management LP boosted its stake in shares of Acadia Healthcare by 675.6% during the 1st quarter. Hawk Ridge Capital Management LP now owns 497,320 shares of the company's stock worth $32,589,000 after purchasing an additional 433,200 shares during the period. 99.79% of the stock is owned by hedge funds and other institutional investors.

Wall Street Analysts Forecast Growth

Several equities research analysts have recently commented on ACHC shares. Jefferies Financial Group boosted their price target on shares of Acadia Healthcare from $85.00 to $95.00 in a report on Thursday, July 28th. Loop Capital started coverage on shares of Acadia Healthcare in a report on Thursday, June 16th. They issued a "hold" rating and a $72.00 price target for the company. SVB Leerink boosted their price target on shares of Acadia Healthcare from $95.00 to $103.00 and gave the company an "outperform" rating in a report on Friday, August 26th. UBS Group boosted their price target on shares of Acadia Healthcare from $82.00 to $90.00 and gave the company a "buy" rating in a report on Thursday, July 28th. Finally, Deutsche Bank Aktiengesellschaft boosted their price target on shares of Acadia Healthcare from $70.00 to $82.00 in a report on Monday, August 1st. Two analysts have rated the stock with a hold rating and three have assigned a buy rating to the company's stock. According to MarketBeat, the company currently has an average rating of "Moderate Buy" and an average price target of $83.88.

Acadia Healthcare Trading Down 2.6 %

Acadia Healthcare (NASDAQ:ACHC – Get Rating) last issued its quarterly earnings results on Wednesday, July 27th. The company reported $0.84 earnings per share (EPS) for the quarter, beating analysts' consensus estimates of $0.77 by $0.07. Acadia Healthcare had a net margin of 11.32% and a return on equity of 10.34%. The business had revenue of $651.72 million for the quarter, compared to analyst estimates of $650.80 million. During the same quarter in the prior year, the business posted $0.71 EPS. Acadia Healthcare's revenue for the quarter was up 11.9% compared to the same quarter last year. As a group, sell-side analysts forecast that Acadia Healthcare Company, Inc. will post 3.08 EPS for the current fiscal year.

Insider Buying and Selling at Acadia Healthcare

In other news, Director William M. Petrie sold 6,000 shares of the company's stock in a transaction on Friday, July 29th. The shares were sold at an average price of $83.42, for a total value of $500,520.00. Following the sale, the director now directly owns 31,769 shares of the company's stock, valued at approximately $2,650,169.98. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through this hyperlink. In other news, Director William Grieco sold 5,000 shares of the company's stock in a transaction on Wednesday, September 7th. The shares were sold at an average price of $82.54, for a total value of $412,700.00. Following the sale, the director now directly owns 73,811 shares of the company's stock, valued at approximately $6,092,359.94. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through this hyperlink. Also, Director William M. Petrie sold 6,000 shares of the company's stock in a transaction on Friday, July 29th. The shares were sold at an average price of $83.42, for a total transaction of $500,520.00. Following the completion of the sale, the director now directly owns 31,769 shares in the company, valued at $2,650,169.98. The disclosure for this sale can be found here. In the last quarter, insiders have sold 34,094 shares of company stock worth $2,788,568. 1.90% of the stock is owned by corporate insiders.

Acadia Healthcare Company Profile

(Get Rating)

Acadia Healthcare Company, Inc provides behavioral healthcare services in the United States and Puerto Rico. The company offers behavioral healthcare services to its patients in various settings, including inpatient psychiatric hospitals, specialty treatment facilities, residential treatment centers, and outpatient clinics.

Featured Articles

• Get a free copy of the StockNews.com research report on Acadia Healthcare (ACHC)
• The Worst May be Over for Target, But is the Stock Safe to Buy?
• Are These Liquid Natural Gas Stocks Ready For An Upside Bounce?
• Two Fun Stocks The Insiders Are Buying
• Novavax Remains a Risk-On Stock in a Risk-Off Market
• General Mills: Superior Returns With Less Volatility

Receive News & Ratings for Acadia Healthcare Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Acadia Healthcare and related companies with MarketBeat.com's FREE daily email newsletter.